Cardiovascular complications in COVID-19

COVID-19, caused by SARS-CoV-2, is known for its systemic inflammation and pulmonary complications leading to significant morbidity and mortality. However, cardiovascular complications are also a critical aspect of the disease. This study aims to evaluate these cardiovascular complications in the context of COVID-19 infection​​. Methods: The authors conducted a literature review using databases like PubMed and Google Scholar. They included various types of studies focusing on COVID-19 and its cardiovascular effects and complications. The literature reviewed encompassed case reports, retrospective and prospective studies, systematic reviews, meta-analyses, and clinical guidelines. In total, 45 articles were selected for inclusion in the study​​.…

The Heart in COVID-19: Primary Target or Secondary Bystander?

The study “The Heart in COVID-19: Primary Target or Secondary Bystander?” delves into the cardiovascular complications associated with COVID-19, highlighting the complex interplay between the virus and heart health. Here is a detailed summary: In summary, this study provides vital insights into the various mechanisms through which COVID-19 can affect cardiovascular health. It underscores the importance of careful consideration of cardiac biomarkers in COVID-19 patients and highlights the need for further research to develop effective therapeutic strategies for managing cardiovascular complications associated with the disease. Read More: https://www.sciencedirect.com/science/article/pii/S2452302X20301546